Location History:
- Bowie, MD (US) (2015)
- West Lafayette, IN (US) (2018 - 2024)
Company Filing History:
8 out of 2,664 
3 out of 1,932 
1 out of 832,891 Years Active: 2015-2025
Title: Innovations and Contributions of Herman O Sintim
Introduction
Herman O Sintim is a notable inventor based in West Lafayette, IN (US), recognized for his significant contributions to the field of medicinal chemistry. With a total of 10 patents to his name, he has made substantial advancements in the development of therapeutic compounds.
Latest Patents
Among his latest patents, one is titled "Inhibitors of kinase networks and uses thereof." This invention relates to compounds that act as dual kinase-demethylase inhibitors, which are useful for treating diseases mediated by kinases and/or histone demethylases. These diseases include inflammation, cancer, viral and bacterial infections, as well as neurological and immunological disorders. The patent also encompasses pharmaceutical compositions and methods for treating these diseases.
Another significant patent is "Inhibitors of cyclic mono- and di-nucleotide phosphodiesterases and the uses thereof." This invention describes compounds that belong to the class of cyclic nucleotides, which play diverse roles in both prokaryotes and eukaryotes. These compounds inhibit phosphodiesterases that affect cyclic mononucleotides or dinucleotides, offering potential applications as antiviral, antibacterial, anti-inflammatory, and anticancer agents, including in cancer immunotherapy.
Career Highlights
Herman O Sintim has worked with esteemed organizations such as the Purdue Research Foundation and the University System of Maryland. His work has significantly impacted the field of drug development and therapeutic interventions.
Collaborations
He has collaborated with notable colleagues, including Clement Opoku-Temeng and Neetu Dayal, contributing to various research projects and innovations.
Conclusion
Herman O Sintim's work exemplifies the intersection of innovation and practical application in the medical field. His patents reflect a commitment to addressing critical health challenges through scientific research and development.